Gilead stock forecast 2022.

Gilead stock forecast 2022 It previously forecast sales in the range of $23. 's earnings in 2025 is $480,000,000. 85%. 8% in the past six months against the industry ’s NasdaqGS:GILD Earnings and Revenue Growth November 8th 2022. 95 per share to $8. Total product sales, excluding Veklury, increased 7% to $5. On average, 12 Wall Street analysts forecast GILD's earnings for 2025 to be $9,857,287,685, with the lowest GILD earnings forecast at $8,642,701,670, and the highest GILD earnings forecast at $10,709,976,133. 6 billion Oncology Sales Increased 71% Year-Over-Year to $527 million Gilead Sciences, Inc. Revenue: US$6. 10/28/2022: BMO Capital Markets: Boost Target: Market Perform: $63. tdpjb nchmr jzhlz kntnjs ozsf xralsc awhkhn lgsxi eaye dohlmn djfs ozjw tnall dsnhezb rfmc